UK's drug bill falls to 11% of NHS spending

5 March 2007

The UK's National Health Service drug bill (hospital and community) has declined as a proportion of overall NHS spending from 12.7% in 1999 to 11% in 2005, according to research published by the Office of Health Economics, a consultancy that is part of the Association of the British Pharmaceutical Industry. In total, the NHS drugs bill was L10.54 billion ($20.69 billion).

The data, published in the 2007 edition of the OHE's annual Compendium of Health Statistics, was calculated from a range of sources, including the government's Prescription Pricing Authority.

The volume of drug prescriptions dispensed rose from 616 million in 1997 to 881 million in 2005, an increase of 35%. The rising cost of newer drugs is reflected in the average price per item over the same period: climbing 27%, from L8.77 to L11.13.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight